Research

    PMI Publications

    We believe scientific results are meant to be shared. There are 1,460 scientists, engineers, technicians, and support staff working in PMI research and development (R&D) as of 2024.

     

    Transparency and open sharing of results and methods promote the use of best practices in scientific research, and the resulting scientific publications and presentations are the base upon which science-based discussions are built. As of 2024, we have published 541 scientific publications since 2008. We welcome you to browse our publications library and see the details of our research for yourself.

     

    You can also browse our literature reviews, which are summaries of a selection of our own as well as independent publications. 

    • Default
    • Ascending
    • Descending
    Publication Type
    Assessment program
    Products

    1397 Results

    Presentations

    Misunderstanding nicotine delivery: Discussion on nicotine pouches

    Wade, C. and Baker, G.

    Jun 19, 2025

    Peer-Reviewed Publications

    AeroSolved: Wall Boundary Conditions for Liquid Multispecies Aerosol Deposition at Transient and High-Humidity Flows

    Zacchei, F.; Lucci, F.; Frederix, E.; Tajfirooz, S.; Kuczaj, A.K.

    Journal of Aerosol Science • May 24, 2025

    Peer-Reviewed Publications

    Bridging Approaches to Facilitate Innovation: Building an Approach for Heated Tobacco Products from Case Studies in the Food and Drug Domains a Comparative Review

    Dempsey, R.; Gunduz, I.; Vanscheeuwijck, P.

    Archives of Toxicology • May 21, 2025

    Peer-Reviewed Publications

    A Comparative Assessment of the FDA List of 93 HPHCs in Aerosol Generated by Tobacco Heating System 2.2 versus 3R4F Reference Cigarette Smoke

    Maeder, S.; Jeannet, C.

    Chemical Research in Toxicology • May 21, 2025

    Peer-Reviewed Publications

    Monoamine Oxidase Inhibitors Present in Tobacco Modulate Dopamine Balance Via the Dopamine Transporter

    Saro, G.; Johne, S.; Latino, D.; Moine, F.; van der Toorn, M.; Veljkovic, E.

    Mar 4, 2025

    Peer-Reviewed Publications

    Tobacco Use, Risk Perceptions, and Characteristics of Adults Who Used a Heated Tobacco Product (IQOS) in the United States: Cross-Sectional Survey Study

    Cheng, H.G.; Noggle, B.; Vansickel, A.R.; Largo, E.G.; Magnani P.

    JMIR Formative Research 2025 • Feb 7, 2025

    Posters

    The evolution of tobacco sales and use following the introduction of heated tobacco products in Japan

    Koumal, O.; Fischer, K.; Seifert, J.

    Oct 28, 2024

    Peer-Reviewed Publications

    Differences in Biomarkers of Potential Harm After 2+ Years of Tobacco Heating System Use Compared to Cigarette Smoking: A Cross-Sectional Study

    Ansari, M.; Leroy, P.; de LaBourdonnaye, G.; Pouly, S.; Reese, L.; Haziza, C.

    Biomarkers • Jan 30, 2025

    Clinical Studies

    Nicotine Pharmacokinetics and Subjective Effects of Nicotine Pouch 1.0 Compared to Velo® Ice Cool and Zyn® Cool Mint Mini Dry in Healthy Smokers

    Apr 7, 2022

    Clinical Studies

    Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes

    May 20, 2022

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.